CLVR vs RARE · rev $17.4M vs rev $350.0M
Clever Leaves Holdings Inc (CLVR) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Clever Leaves Holdings Inc (CLVR) is a drug manufacturers - specialty & generic company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported CLVR revenue for 2023-12-31 was $17.4M. Net income was -$17.9M. Revenue was up 6.1% from 2022-12-31 to 2023-12-31. CLVR currently screens at market cap $1.4K.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
CLVR currently screens at market cap $1.4K. RARE currently screens at market cap $2.79B.
Not investment advice. Open the CLVR and RARE stock pages for the full models.
Not investment advice.